Investor enthusiasm remains high ahead of the listing, with the company's shares commanding a grey market premium (GMP) of around Rs 50, translating to nearly 36% above the upper issue price of Rs 138. Based on current GMP trends, the stock is expected to list at around Rs 188 per share, suggesting healthy listing gains for investors, although grey market premiums are unofficial and may not accurately predict the actual listing price.